Biofrontera Inc.
BFRINASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $10.95M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.55$1.66
- Volume (live)
- -
- Avg. volume (3M)
- 577.76K
Biofrontera (BFRI) Stock Price & Financial Analysis
Biofrontera Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.82 - $0.92 |
|---|---|
| 52-Week High | $1.66 |
| 52-Week Low | $0.55 |
| Open | $0.88 |
| Volume (last close) | 202.86K |
| Average Volume (3M) | 577.76K |
| Revenue (TTM) | 46.17M |
|---|---|
| Net Income (TTM) | -6.37M |
| Free Cash Flow (TTM) | -7.93M |
| EPS (TTM) | −$0.54 |
| Profit Margin | -13.78% |
| Operating Margin | -14.21% |
| Return on Equity (ROE) | -106.87% |
| Debt to Equity | 0.85 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 10.95M |
|---|---|
| Shares Outstanding | 12.92M |
| Price to Sales (P/S) | 0.24 |
| Price to Book (P/B) | 1.84 |
| EV/EBITDA | -2.30 |
| 50-Day MA | $1.27 |
|---|---|
| 200-Day MA | $1.03 |
| 1-Year Change | −11.76% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Biofrontera at a Glance
As of the Oct 16, 2026 close, Biofrontera (BFRI) has a market capitalization of $10.95M. The stock trades at 0.2× sales. Over the trailing twelve months it lost $6.37M on revenue of $46.17M and burned $7.93M of free cash flow. Revenue grew 17.8% year over year.
As of its latest reported balance sheet, it holds $4.66M in cash and securities against $5.09M of debt, a net debt position of $433.00K.
Biofrontera does not currently pay a dividend.
The share price is down 11.8% over the past year. At $0.82 (the Oct 16, 2026 close) it sits within its 52-week range of $0.55 to $1.66, below its 200-day moving average of $1.03.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Biofrontera
What is the current stock price for BFRI?
As of the Oct 16, 2026 close, BFRI stock trades at $0.82. The 52-week range is $0.55–$1.66, with a day range of $0.82–$0.92.
What is the P/E ratio for BFRI?
The P/E ratio (Price-to-Earnings) for BFRI is shown in the Key Statistics section. This valuation metric helps compare Biofrontera Inc. to industry peers.
Does BFRI pay dividends?
Biofrontera does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BFRI?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for BFRI is Buy.
What is the market cap of BFRI?
As of the Oct 16, 2026 close, Biofrontera's market capitalization is $10.6M, classifying it as a micro-cap company. Biofrontera operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.